<DOC>
	<DOCNO>NCT00359177</DOCNO>
	<brief_summary>The purpose study evaluate subject mild moderate liver problem process breakdown study drug GW679769 body compare healthy subject .</brief_summary>
	<brief_title>Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<criteria>Inclusion criterion : Healthy mild moderate hepatic impairment Females : Nonchildbearing ( hysterectomy , bilateral oophorectomy , postmenopausal ) , childbearing ( negative pregnancy test , abstinence , doublebarrier contraception , vasectomized partner ) Negative Hepatitis B C ( healthy subject ) Negative drug , alcohol HIV test Exclusion criterion : Fluctuating rapidly deteriorate hepatic function abnormal kidney function Encephalopathy Active peptic ulcer disease Drug alcohol abuse Pregnant lactate Esophageal bleed Heart failure Infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>emesis liver problem hepatic impairment GW679769</keyword>
</DOC>